Schrage William G, Joyner Michael J, Dinenno Frank A
Department Anaesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
J Physiol. 2004 Jun 1;557(Pt 2):599-611. doi: 10.1113/jphysiol.2004.061283. Epub 2004 Mar 26.
We tested the hypothesis that inhibition of synthesis of either nitric oxide (NO) or vasodilating prostaglandins (PGs) would not alter exercise hyperaemia significantly, but combined inhibition would synergistically reduce the hyperaemia. Fourteen subjects performed 20 min of moderate rhythmic forearm exercise (10% maximal voluntary contraction). Forearm blood flow (FBF) was measured by Doppler ultrasound. Saline or study drugs were infused (2 ml x min(-1)) into the forearm via a brachial artery catheter to locally inhibit synthesis of NO and PGs during steady state exercise (N(G)-nitro-L-arginine methyl ester (L-NAME), 25 mg over 5 min to inhibit NO synthase (NOS); and ketorolac, 3 mg over 5 min to inhibit cyclooxygenase (COX)). After achieving steady state exercise over 5 min (control), L-NAME was infused for 5 min, followed by 2 min saline, then by a 5 min infusion of ketorolac, and finally by 3 min of saline (n= 7). Drug order was reversed in seven additional subjects, such that single inhibition of NOS or COX was followed by combined inhibition. FBF during exercise decreased to 83 +/- 2% of control exercise (100%) with NOS inhibition, followed by a transient decrease to 68 +/- 2% of control during COX inhibition. However, FBF returned to levels similar to those achieved during NOS inhibition within 2 min (80 +/- 3% of control) and remained stable through the final 3 min of exercise. When COX inhibition was performed first, FBF decreased transiently to 88 +/- 4% of control (P < 0.01), and returned to control saline levels by the end of ketorolac infusion. Addition of L-NAME reduced FBF to 83 +/- 3% of control, and it remained stable through to the end of exercise. Regardless of drug order, FBF was approximately 80% of steady state control exercise (P < 0.01) during the last 30 s of exercise. We conclude that (1). NO provides a significant, consistent contribution to hyperaemia, (2). PGs contribute modestly and transiently, suggesting a redundant signal compensates for the loss of vasodilating PGs, and (3). NO and PG signals appear to contribute independently to forearm exercise hyperaemia.
抑制一氧化氮(NO)或血管舒张性前列腺素(PGs)的合成不会显著改变运动性充血,但联合抑制会协同降低充血程度。14名受试者进行了20分钟的中等强度有节奏的前臂运动(最大自主收缩的10%)。通过多普勒超声测量前臂血流量(FBF)。在稳态运动期间,通过肱动脉导管将生理盐水或研究药物(2 ml·min⁻¹)注入前臂,以局部抑制NO和PGs的合成(N⁰-硝基-L-精氨酸甲酯(L-NAME),5分钟内注入25 mg以抑制一氧化氮合酶(NOS);酮咯酸,5分钟内注入3 mg以抑制环氧化酶(COX))。在5分钟内达到稳态运动(对照)后,注入L-NAME 5分钟,接着注入2分钟生理盐水,然后注入5分钟酮咯酸,最后注入3分钟生理盐水(n = 7)。另外7名受试者的药物注射顺序相反,即先单独抑制NOS或COX,然后联合抑制。运动期间,抑制NOS时FBF降至对照运动(100%)的83±2%,接着在抑制COX期间短暂降至对照的68±2%。然而,FBF在2分钟内恢复到与抑制NOS时相似的水平(对照的80±3%),并在运动的最后3分钟保持稳定。当先进行COX抑制时,FBF短暂降至对照的88±4%(P < 0.01),并在酮咯酸输注结束时恢复到对照生理盐水水平。添加L-NAME使FBF降至对照的83±3%,并在运动结束前保持稳定。无论药物注射顺序如何,在运动的最后30秒内,FBF约为稳态对照运动的80%(P < 0.01)。我们得出结论:(1). NO对充血有显著且持续的贡献;(2). PGs的贡献适度且短暂,表明存在冗余信号来补偿血管舒张性PGs的损失;(3). NO和PG信号似乎对前臂运动性充血有独立贡献。